These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Hyperaldosteronism and altered expression of an SGK1-dependent sodium transporter in ZDF rats leads to salt dependence of blood pressure. Resch M; Bergler T; Fredersdorf S; Griese DP; Weil J; Kreuzer P; Brunner S; Riegger GA; Luchner A; Endemann DH Hypertens Res; 2010 Oct; 33(10):1082-8. PubMed ID: 20664544 [TBL] [Abstract][Full Text] [Related]
3. Eplerenone prevents salt-induced vascular remodeling and cardiac fibrosis in stroke-prone spontaneously hypertensive rats. Endemann DH; Touyz RM; Iglarz M; Savoia C; Schiffrin EL Hypertension; 2004 Jun; 43(6):1252-7. PubMed ID: 15117913 [TBL] [Abstract][Full Text] [Related]
4. Resistance artery mechanics and composition in angiotensin II-infused rats: effects of aldosterone antagonism. Neves MF; Virdis A; Schiffrin EL J Hypertens; 2003 Jan; 21(1):189-98. PubMed ID: 12544451 [TBL] [Abstract][Full Text] [Related]
5. Increased carotid wall elastic modulus and fibronectin in aldosterone-salt-treated rats: effects of eplerenone. Lacolley P; Labat C; Pujol A; Delcayre C; Benetos A; Safar M Circulation; 2002 Nov; 106(22):2848-53. PubMed ID: 12451013 [TBL] [Abstract][Full Text] [Related]
6. Eplerenone attenuated cardiac steatosis, apoptosis and diastolic dysfunction in experimental type-II diabetes. Ramírez E; Klett-Mingo M; Ares-Carrasco S; Picatoste B; Ferrarini A; Rupérez FJ; Caro-Vadillo A; Barbas C; Egido J; Tuñón J; Lorenzo Ó Cardiovasc Diabetol; 2013 Nov; 12():172. PubMed ID: 24261558 [TBL] [Abstract][Full Text] [Related]
7. Rosiglitazone prevents the onset of hyperglycaemia and proteinuria in the Zucker diabetic fatty rat. Smith SA; Lister CA; Toseland CD; Buckingham RE Diabetes Obes Metab; 2000 Dec; 2(6):363-72. PubMed ID: 11225966 [TBL] [Abstract][Full Text] [Related]
8. Aldosterone Synthase Inhibition Improves Glucose Tolerance in Zucker Diabetic Fatty (ZDF) Rats. Hofmann A; Brunssen C; Peitzsch M; Martin M; Mittag J; Jannasch A; Engelmann F; Brown NF; Weldon SM; Huber J; Streicher R; Deussen A; Eisenhofer G; Bornstein SR; Morawietz H Endocrinology; 2016 Oct; 157(10):3844-3855. PubMed ID: 27526033 [TBL] [Abstract][Full Text] [Related]
9. Antidiabetic treatment restores adiponectin serum levels and APPL1 expression, but does not improve adiponectin-induced vasodilation and endothelial dysfunction in Zucker diabetic fatty rats. Schmid PM; Resch M; Schach C; Birner C; Riegger GA; Luchner A; Endemann DH Cardiovasc Diabetol; 2013 Mar; 12():46. PubMed ID: 23497197 [TBL] [Abstract][Full Text] [Related]
10. Effects of enalapril, tempol, and eplerenone on salt-induced hypertension in dahl salt-sensitive rats. Bayorh MA; Mann G; Walton M; Eatman D Clin Exp Hypertens; 2006 Feb; 28(2):121-32. PubMed ID: 16546838 [TBL] [Abstract][Full Text] [Related]
11. Type 2 diabetes severely impairs structural and functional adaptation of rat resistance arteries to chronic changes in blood flow. Belin de Chantemèle EJ; Vessières E; Guihot AL; Toutain B; Maquignau M; Loufrani L; Henrion D Cardiovasc Res; 2009 Mar; 81(4):788-96. PubMed ID: 19050009 [TBL] [Abstract][Full Text] [Related]
13. The AGE-breaker ALT-711 restores high blood flow-dependent remodeling in mesenteric resistance arteries in a rat model of type 2 diabetes. Freidja ML; Tarhouni K; Toutain B; Fassot C; Loufrani L; Henrion D Diabetes; 2012 Jun; 61(6):1562-72. PubMed ID: 22415880 [TBL] [Abstract][Full Text] [Related]
14. Crosstalk between cardiomyocyte-rich perivascular tissue and coronary arteries is reduced in the Zucker Diabetic Fatty rat model of type 2 diabetes mellitus. Bonde L; Shokouh P; Jeppesen PB; Boedtkjer E Acta Physiol (Oxf); 2017 Jan; 219(1):227-238. PubMed ID: 27042951 [TBL] [Abstract][Full Text] [Related]
15. Endothelin antagonism on aldosterone-induced oxidative stress and vascular remodeling. Pu Q; Neves MF; Virdis A; Touyz RM; Schiffrin EL Hypertension; 2003 Jul; 42(1):49-55. PubMed ID: 12782645 [TBL] [Abstract][Full Text] [Related]
16. Oral treatment with a zinc complex of acetylsalicylic acid prevents diabetic cardiomyopathy in a rat model of type-2 diabetes: activation of the Akt pathway. Korkmaz-Icöz S; Al Said S; Radovits T; Li S; Brune M; Hegedűs P; Atmanli A; Ruppert M; Brlecic P; Lehmann LH; Lahrmann B; Grabe N; Yoshikawa Y; Yasui H; Most P; Karck M; Szabó G Cardiovasc Diabetol; 2016 May; 15():75. PubMed ID: 27153943 [TBL] [Abstract][Full Text] [Related]